Billing and Coding: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy

This billing and coding article does not establish independent coverage criteria; instead, billing, coding, documentation, limitations, and frequency rules for HLA-DQB1*06:02 testing for narcolepsy are governed by the associated LCD L37003. Providers and billers must consult LCD L37003 for the specific medical necessity indications, exclusions, required documentation, and any limits on testing prior to claim submission.

"Coverage indications for HLA-DQB1*06:02 testing are specified in the associated LCD L37003 and must be followed for claims under this billing/coding article."

Sign up to see full coverage criteria, indications, and limitations.